|
|
|
Volumn 26, Issue 5 Suppl 17, 1999, Pages 1-68
|
|
Docetaxel (Taxotere): a new option for the treatment of hormone-refractory prostate cancer. Proceedings of a symposium. Chicago, Illinois, USA. April 23, 1999.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
CONFERENCE PAPER;
HUMAN;
MALE;
NEOPLASM;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
HUMANS;
MALE;
NEOPLASMS, HORMONE-DEPENDENT;
PACLITAXEL;
PROSTATIC NEOPLASMS;
TAXOIDS;
|
|
EID: 0033209044
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|